4 Ensemble Capital Sarepta Therapeutics Trades
The first Sarepta Therapeutics trade was made in Q1 2017. Since then Ensemble Capital bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2018 and doesn't own any shares in Sarepta Therapeutics anymore.
News about Sarepta Therapeutics Inc and Ensemble Capital
Here’s What Bronte Capital Calls “Sarepta Risk” in the Context of Sarepta Therapeutics (SRPT)
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here....
Shake Shack, Western Digital rise; Oneok, H&R Block fall
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Oneok Inc., down $ to $5.77 to $57.95. The natural gas company is buying ...
Sarepta Therapeutics PT Raised to $160 at RBC Capital
https://www.investing.com/news/pro/sarepta-therapeutics-pt-raised-to-160-at-rbc-capital-432SI-2861773
Consonance Capital Management LP Buys Surrozen Inc, ARYA Sciences Acquisition Corp V, Olink ...
Related Stocks: SRZN , ARYE , OLK , PTGX , LEGN , VSTM , KROS , SRPT , AFMD ,